Naropin 2 mg/ml

Naropin 2 mg/ml is a medicine authorised by Swissmedic under authorisation number 54015. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 27 February 1997 and the authorisation is valid without a time limit. ATC code N01BB09 places the medicine in the group Anesthetics.

  • Dispensing category B
  • Authorisation number 54015
  • ATC N01BB09
  • Synthetic medicines
Authorisation data
Authorisation number54015
NameNaropin 2 mg/ml
Full nameNaropin 2 mg/ml, Injektions-/Infusionslösung
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN01BB09
First authorisation27 February 1997
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Naropin 2 mg/ml, Injektions-/InfusionslösungB27 February 1997
2Naropin 7.5 mg/ml, InjektionslösungB27 February 1997
3Naropin 10 mg/ml, InjektionslösungB27 February 1997
4Naropin 5 mg/ml, InjektionslösungB26 February 2001

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
15 x 10mlN01BB0901.02.2.B
25 x 20mlN01BB0901.02.2.B
1191 x 5 x 200mlN01BB0901.02.2.B
35 x 10mlN01BB0901.02.2.B
45 x 20mlN01BB0901.02.2.B
55 x 10mlN01BB0901.02.2.B
65 x 10mlN01BB0901.02.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Naropin 2 mg/ml authorised in Switzerland?

Yes. Naropin 2 mg/ml is authorised by Swissmedic under authorisation number 54015, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Naropin 2 mg/ml have?

Naropin 2 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Naropin 2 mg/ml?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com